Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Patient characteristics by SARS-CoV-2 testing status, March 1, 2020-August 31, 2020.

More »

Table 1 Expand

Table 2.

Patient characteristics by Cohort, March 1, 2020-August 31, 2020.

More »

Table 2 Expand

Fig 1.

Racial/ethnic and sex differences in COVID-19 outcomes in clinical cohorts for (A) SARS-CoV-2 testing, (B) positivity, (C) hospitalization, and (D) death. Overall percentages are calculated among clinical cohort population (N = 5,304,631). Percentages by sex are calculated out of the overall number of members within each race group. Asian/PI = Asian/Pacific Islander.

More »

Fig 1 Expand

Table 3.

Risk ratios of (A) SARS-CoV-2 testing, (B) positivity, (C) hospitalization, and (D) death.

Risk ratios by race compared to White, Non-Hispanic persons; risk ratios by sex compared to Female persons. Specific CIVET cohort site names have been masked.

More »

Table 3 Expand

Fig 2.

Racial/ethnic and sex differences in COVID-19 outcomes in clinical cohorts stratified by health system classification for (A) SARS-CoV-2 testing, (B) positivity, (C) hospitalization, and (D) death. Overall percentages are calculated among clinical cohort population (N = 5,304,631). Asian/PI = Asian/Pacific Islander.

More »

Fig 2 Expand